Hemodialysis is a therapy that filters waste, removes extra fluid and balances electrolytes (sodium, potassium, bicarbonate, chloride, calcium, magnesium and phosphate).
The global Hemodialysis Service market was valued at US$ 648 million in 2023 and is anticipated to reach US$ 949.9 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The hemodialysis service market is gradually growing, with an expanding market size and steadily increasing sales globally. This service is primarily used to treat patients with kidney diseases, especially those with chronic kidney disease, providing essential blood purification. In the future, the market is expected to continue expanding, benefiting from a growing population of patients with chronic illnesses and ongoing innovations in medical technology. With the increasing trend of aging populations and improvements in healthcare systems, the hemodialysis service industry will continue to evolve and offer a broader range of treatment options.
This report aims to provide a comprehensive presentation of the global market for Hemodialysis Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemodialysis Service.
Report Scope
The Hemodialysis Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemodialysis Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemodialysis Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Âé¶¹Ô´´ Segmentation
By Company
Fresenius
Baxter
US Renal Care
DaVita
Mayo Clinic
American Renal Associates
Bangkok Hospital
Halton Healthcare
Dialysis Clinic
WEGO
3SBio Group
Dakang Medical
Shinva Medical
Segment by Type
Acute Hemodialysis
Chronic Hemodialysis
Segment by Application
Hospital
Dialysis Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemodialysis Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Hemodialysis Service Âé¶¹Ô´´ Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Acute Hemodialysis
1.2.3 Chronic Hemodialysis
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Hemodialysis Service Âé¶¹Ô´´ Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Dialysis Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemodialysis Service Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Hemodialysis Service Growth Trends by Region
2.2.1 Global Hemodialysis Service Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hemodialysis Service Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Hemodialysis Service Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Hemodialysis Service Âé¶¹Ô´´ Dynamics
2.3.1 Hemodialysis Service Industry Trends
2.3.2 Hemodialysis Service Âé¶¹Ô´´ Drivers
2.3.3 Hemodialysis Service Âé¶¹Ô´´ Challenges
2.3.4 Hemodialysis Service Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemodialysis Service Players by Revenue
3.1.1 Global Top Hemodialysis Service Players by Revenue (2019-2024)
3.1.2 Global Hemodialysis Service Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Hemodialysis Service Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hemodialysis Service Revenue
3.4 Global Hemodialysis Service Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Hemodialysis Service Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemodialysis Service Revenue in 2023
3.5 Hemodialysis Service Key Players Head office and Area Served
3.6 Key Players Hemodialysis Service Product Solution and Service
3.7 Date of Enter into Hemodialysis Service Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemodialysis Service Breakdown Data by Type
4.1 Global Hemodialysis Service Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Hemodialysis Service Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Hemodialysis Service Breakdown Data by Application
5.1 Global Hemodialysis Service Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Hemodialysis Service Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Hemodialysis Service Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Hemodialysis Service Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hemodialysis Service Âé¶¹Ô´´ Size by Country (2019-2024)
6.4 North America Hemodialysis Service Âé¶¹Ô´´ Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hemodialysis Service Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Hemodialysis Service Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hemodialysis Service Âé¶¹Ô´´ Size by Country (2019-2024)
7.4 Europe Hemodialysis Service Âé¶¹Ô´´ Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemodialysis Service Âé¶¹Ô´´ Size (2019-2030)
8.2 Asia-Pacific Hemodialysis Service Âé¶¹Ô´´ Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hemodialysis Service Âé¶¹Ô´´ Size by Region (2019-2024)
8.4 Asia-Pacific Hemodialysis Service Âé¶¹Ô´´ Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hemodialysis Service Âé¶¹Ô´´ Size (2019-2030)
9.2 Latin America Hemodialysis Service Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hemodialysis Service Âé¶¹Ô´´ Size by Country (2019-2024)
9.4 Latin America Hemodialysis Service Âé¶¹Ô´´ Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemodialysis Service Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East & Africa Hemodialysis Service Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hemodialysis Service Âé¶¹Ô´´ Size by Country (2019-2024)
10.4 Middle East & Africa Hemodialysis Service Âé¶¹Ô´´ Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fresenius
11.1.1 Fresenius Company Detail
11.1.2 Fresenius Business Overview
11.1.3 Fresenius Hemodialysis Service Introduction
11.1.4 Fresenius Revenue in Hemodialysis Service Business (2019-2024)
11.1.5 Fresenius Recent Development
11.2 Baxter
11.2.1 Baxter Company Detail
11.2.2 Baxter Business Overview
11.2.3 Baxter Hemodialysis Service Introduction
11.2.4 Baxter Revenue in Hemodialysis Service Business (2019-2024)
11.2.5 Baxter Recent Development
11.3 US Renal Care
11.3.1 US Renal Care Company Detail
11.3.2 US Renal Care Business Overview
11.3.3 US Renal Care Hemodialysis Service Introduction
11.3.4 US Renal Care Revenue in Hemodialysis Service Business (2019-2024)
11.3.5 US Renal Care Recent Development
11.4 DaVita
11.4.1 DaVita Company Detail
11.4.2 DaVita Business Overview
11.4.3 DaVita Hemodialysis Service Introduction
11.4.4 DaVita Revenue in Hemodialysis Service Business (2019-2024)
11.4.5 DaVita Recent Development
11.5 Mayo Clinic
11.5.1 Mayo Clinic Company Detail
11.5.2 Mayo Clinic Business Overview
11.5.3 Mayo Clinic Hemodialysis Service Introduction
11.5.4 Mayo Clinic Revenue in Hemodialysis Service Business (2019-2024)
11.5.5 Mayo Clinic Recent Development
11.6 American Renal Associates
11.6.1 American Renal Associates Company Detail
11.6.2 American Renal Associates Business Overview
11.6.3 American Renal Associates Hemodialysis Service Introduction
11.6.4 American Renal Associates Revenue in Hemodialysis Service Business (2019-2024)
11.6.5 American Renal Associates Recent Development
11.7 Bangkok Hospital
11.7.1 Bangkok Hospital Company Detail
11.7.2 Bangkok Hospital Business Overview
11.7.3 Bangkok Hospital Hemodialysis Service Introduction
11.7.4 Bangkok Hospital Revenue in Hemodialysis Service Business (2019-2024)
11.7.5 Bangkok Hospital Recent Development
11.8 Halton Healthcare
11.8.1 Halton Healthcare Company Detail
11.8.2 Halton Healthcare Business Overview
11.8.3 Halton Healthcare Hemodialysis Service Introduction
11.8.4 Halton Healthcare Revenue in Hemodialysis Service Business (2019-2024)
11.8.5 Halton Healthcare Recent Development
11.9 Dialysis Clinic
11.9.1 Dialysis Clinic Company Detail
11.9.2 Dialysis Clinic Business Overview
11.9.3 Dialysis Clinic Hemodialysis Service Introduction
11.9.4 Dialysis Clinic Revenue in Hemodialysis Service Business (2019-2024)
11.9.5 Dialysis Clinic Recent Development
11.10 WEGO
11.10.1 WEGO Company Detail
11.10.2 WEGO Business Overview
11.10.3 WEGO Hemodialysis Service Introduction
11.10.4 WEGO Revenue in Hemodialysis Service Business (2019-2024)
11.10.5 WEGO Recent Development
11.11 3SBio Group
11.11.1 3SBio Group Company Detail
11.11.2 3SBio Group Business Overview
11.11.3 3SBio Group Hemodialysis Service Introduction
11.11.4 3SBio Group Revenue in Hemodialysis Service Business (2019-2024)
11.11.5 3SBio Group Recent Development
11.12 Dakang Medical
11.12.1 Dakang Medical Company Detail
11.12.2 Dakang Medical Business Overview
11.12.3 Dakang Medical Hemodialysis Service Introduction
11.12.4 Dakang Medical Revenue in Hemodialysis Service Business (2019-2024)
11.12.5 Dakang Medical Recent Development
11.13 Shinva Medical
11.13.1 Shinva Medical Company Detail
11.13.2 Shinva Medical Business Overview
11.13.3 Shinva Medical Hemodialysis Service Introduction
11.13.4 Shinva Medical Revenue in Hemodialysis Service Business (2019-2024)
11.13.5 Shinva Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Fresenius
Baxter
US Renal Care
DaVita
Mayo Clinic
American Renal Associates
Bangkok Hospital
Halton Healthcare
Dialysis Clinic
WEGO
3SBio Group
Dakang Medical
Shinva Medical
Ìý
Ìý
*If Applicable.